Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Meyer

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
American Heart Journal|December 13, 2005
Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trialVeselin Mitrovic, Hartmut Lüss, Klaus Nitsche, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2021
SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent proteinMaren E Arnold, Wolfgang R Dostmann, Jody Martin, et al.
Journal of Vascular Surgery|February 1, 2011
Endovascular management of ascending aortic pathologyRalf R Kolvenbach, Ron Karmeli, Lazlo S Pinter, et al.
The American Journal of Emergency Medicine|June 21, 2020
Potential role of telemedicine in solving ST-segment elevation dilemmas in remote areas during the COVID-19 pandemicRaymond Pranata, Alexander Edo Tondas, Ian Huang, et al.
Journal of Clinical and Translational Research|September 20, 2021
Indonesian medical frontliners during the coronavirus disease 2019 pandemic: Have we been protecting them enough?Gilbert Lazarus, Markus Meyer, Markus Depfenhart, et al.
European Journal of Heart Failure|February 27, 2026
Normal abundance of immune cells in left ventricular myocardium from patients with heart failure and preserved ejection fractionBo Ye, Yuyong Xu, Fuyuki Hirashima, et al.
The Journal of General Physiology|March 21, 2020
Enhancing diastolic function by strain-dependent detachment of cardiac myosin crossbridgesBradley M Palmer, Douglas M Swank, Mark S Miller, et al.
Danish Medical Journal|December 1, 2021
Ularitide as treatment of refractory ascites in cirrhosis- a study protocol for a randomised trialRasmus Hvidbjerg Gantzel, Markus Meyer, Stefan Mazgareanu, et al.
Journal of Cardiac Failure|October 31, 2024
Physiological Pacing for the Prevention and Treatment of Heart Failure: a State-of-the-Art ReviewMargaret Infeld, Jamie A Cyr, Damián Sánchez-Quintana, et al.
JAMA Network Open|December 5, 2019
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT TrialDaniel N Silverman, Timothy B Plante, Margaret Infeld, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
American Heart Journal|December 13, 2005
Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trialVeselin Mitrovic, Hartmut Lüss, Klaus Nitsche, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2021
SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent proteinMaren E Arnold, Wolfgang R Dostmann, Jody Martin, et al.
Journal of Vascular Surgery|February 1, 2011
Endovascular management of ascending aortic pathologyRalf R Kolvenbach, Ron Karmeli, Lazlo S Pinter, et al.
The American Journal of Emergency Medicine|June 21, 2020
Potential role of telemedicine in solving ST-segment elevation dilemmas in remote areas during the COVID-19 pandemicRaymond Pranata, Alexander Edo Tondas, Ian Huang, et al.
Journal of Clinical and Translational Research|September 20, 2021
Indonesian medical frontliners during the coronavirus disease 2019 pandemic: Have we been protecting them enough?Gilbert Lazarus, Markus Meyer, Markus Depfenhart, et al.
European Journal of Heart Failure|February 27, 2026
Normal abundance of immune cells in left ventricular myocardium from patients with heart failure and preserved ejection fractionBo Ye, Yuyong Xu, Fuyuki Hirashima, et al.
The Journal of General Physiology|March 21, 2020
Enhancing diastolic function by strain-dependent detachment of cardiac myosin crossbridgesBradley M Palmer, Douglas M Swank, Mark S Miller, et al.
Danish Medical Journal|December 1, 2021
Ularitide as treatment of refractory ascites in cirrhosis- a study protocol for a randomised trialRasmus Hvidbjerg Gantzel, Markus Meyer, Stefan Mazgareanu, et al.
Journal of Cardiac Failure|October 31, 2024
Physiological Pacing for the Prevention and Treatment of Heart Failure: a State-of-the-Art ReviewMargaret Infeld, Jamie A Cyr, Damián Sánchez-Quintana, et al.
JAMA Network Open|December 5, 2019
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT TrialDaniel N Silverman, Timothy B Plante, Margaret Infeld, et al.
Pageof 15